.png)
Irvine, CA (PRWEB) September 12, 2017
BioMedGPS, the leading provider of real-time analytics and strategic intelligence of the orthopedic/spine, wound care, regenerative medicine and neuro therapies markets, announces expanded coverage of SmartTRAK Business Intelligence for the European market with the addition of modules in SmartTRAK EU Extremities and EU Trauma.
SmartTRAK will be at this year's #AVA2017 Association for Vascular Access 2017 Annual Scientific Meeting in Phoenix, Arizona. This year's conference promises to be invaluable for industry learnings and networking. Susan Paquette, VP & General Manager SmartTRAK Wound, will also be in attendance, covering the latest research and technologies and participating in this year's informative agenda.
Durham-based Bioventus has received approval from the U.S. Food and Drug Administration for its treatment, Durolane.
The single-injection product treats knee osteoarthritis pain. The company plans to launch Durolane in the U.S. early next year.
Citing BioMedGPS SmartTRAK, Bioventus CEO Tony Bihl said in an email that “the 2016 entire HA market in the US (1-shot, 2-shot, 3-shot and 5-shot) was about $979 million.”
International Neuromodulation Society (INS) President Tim Deer, MD discusses important research results as well as key trends and technologies in neuromodulation.
Timothy Deer, MD, FIPP, President of the International Neuromodulation Society (INS), at the INS 13th Annual Congress May 26-June 3 highlighted key studies, trends and technologies in neuromodulation in an interview with SmartTRAK in Edinburgh, Scotland...
Max Retail Pricing for Knees in India Dropping up to 78%
The Indian Government enacted price controls for knee implants capping the price significantly below current market rates. According to a report in IndiaToday , the move is the latest step in the government’s move to bring down the cost of medical devices and pharmaceuticals. The price controls for knee replacement implants caps the price of CoCr knees at ~$852 (54,720 rupees). Ananth Kumar, Minister of Chemicals and Fertilisers, stated current implants are priced at up to ~$3,895 (250K rupees) at Indian hospitals...
SmartTRAK Customer Testimonial
SmartTRAK customer Tyler Trapani, Product Manager, tells why SmartTRAK is an essential tool that keeps him up-to-date on market trends and competitors.
Tyler Trapani Video Testimonial
Doug Devens has joined SmartTRAK to cover new Hemostats & Sealants area including Surgical Matrices
SmartTRAK is happy to introduce you to the newest member of the SmartTRAK team, Doug Devens, PhD. Doug will be heading up our Biosurgery efforts, including our newest segment in Advanced Wound Care, Hemostats and Sealants; and Surgical Matrices – both Hernia and Breast. The new Hemostats & Sealants area covers over 27 companies and 55 products on a global basis, with several currently in development.
-1.png?t=1500739086786&width=600&height=200&name=Copy%20of%20Email%20Banner%20Recorded%20Webinar%20New%20Features%20(1)-1.png)
We have just launched SmartTRAK 2.0, the premier Business Intelligence Data Platform in the Orthopedics, Wound Care and Neuro Therapies spaces.
Innovation and clinical outcomes are shaping the future of the US ventral hernia market. Over the next several years, the market will see a continued shift from biologic mesh to synthetic mesh, growth in robotic hernia repairs, and an increased focus on clinical efficacy and economic outcomes data that will drive product adoption and impact market shares, particularly in the biosynthetic segment.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.
Robust growth is predicted for the US OrthoBio market, driving revenues to over $4B by 2021E according to SmartTRAK projections.